International Journal of Rheumatic Diseases

Papers
(The H4-Index of International Journal of Rheumatic Diseases is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
45
Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population42
40
Misdiagnosis and delayed diagnosis of atypical autoimmune pancreatitis: Experience from clinical cases35
Issue Information35
34
29
Aortic‐vertebral interaction in inflammation29
Sclerotic bone lesions: Think about tuberous sclerosis too28
A rare case of IgG4‐associated disease caused by COVID‐19: Case report and literature review28
Molecules in the hippo pathway that regulate Th17 differentiation reveal the severity of ankylosing spondylitis28
Avoidance of allergen exposure may ameliorate IgG4‐related disease: A case that improved spontaneously after moving house27
Ankylosing spondylitis shares a common therapeutic target with breast cancer24
Patellar gout: An important mimic of patellar tumor24
A Bidirectional Mendelian Randomization Study of Tea‐Drinking Habits and Risk of Elevated Serum Uric Acid Levels23
Positive FDG‐PET/CT uptake guiding diagnosis in a patient with microscopic polyangiitis: A case report23
23
A case of clinically amyopathic dermatomyositis in a Filipino woman23
Case Report: A Diagnostic Challenge in Adult‐Onset Hypophosphatasia With Persistent Polyarthralgia22
Impact of folic acid on regulatory B lymphocytes from patients with systemic lupus erythematosus in vitro22
Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus20
Editorial: The role of Piezo 1 in osteoarthritis: Implications for pathogenesis and therapy20
Balancing Effective Treatments With Potential Threats: The Impact of Biologic Agent Use on Tuberculosis Development in Children With Chronic Inflammatory Disorders20
0.77964520454407